Cargando…
Investigation of the key chemical structures involved in the anticancer activity of disulfiram in A549 non-small cell lung cancer cell line
BACKGROUND: Disulfiram (DS), an antialcoholism medicine, demonstrated strong anticancer activity in the laboratory but did not show promising results in clinical trials. The anticancer activity of DS is copper dependent. The reaction of DS and copper generates reactive oxygen species (ROS). After or...
Autores principales: | Butcher, Kate, Kannappan, Vinodh, Kilari, Rajagopal Sharada, Morris, Mark R., McConville, Christopher, Armesilla, Angel L., Wang, Weiguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054747/ https://www.ncbi.nlm.nih.gov/pubmed/30031402 http://dx.doi.org/10.1186/s12885-018-4617-x |
Ejemplares similares
-
The cytotoxic mechanisms of disulfiram and copper(ii) in cancer cells
por: Tawari, Patricia Erebi, et al.
Publicado: (2015) -
Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
por: Kannappan, Vinodh, et al.
Publicado: (2021) -
Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells
por: Wang, Zhipeng, et al.
Publicado: (2017) -
Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo
por: Liu, Peng, et al.
Publicado: (2014) -
Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment
por: Najlah, Mohammad, et al.
Publicado: (2019)